Peter C M van Zijl Selected Research

APT

1/2022	Review and consensus recommendations on clinical APT-weighted imaging approaches at 3T: Application to brain tumors.
1/2021	APT-weighted MRI Can Be an Early Marker for Demyelination.
1/2017	Improving the detection sensitivity of pH-weighted amide proton transfer MRI in acute stroke patients using extrapolated semisolid magnetization transfer reference signals.
1/2016	Applying amide proton transfer-weighted MRI to distinguish pseudoprogression from true progression in malignant gliomas.
1/2016	Whole-brain amide proton transfer (APT) and nuclear overhauser enhancement (NOE) imaging in glioma patients using low-power steady-state pulsed chemical exchange saturation transfer (CEST) imaging at 7T.
7/2015	Simultaneous detection and separation of hyperacute intracerebral hemorrhage and cerebral ischemia using amide proton transfer MRI.
11/2013	Three-dimensional amide proton transfer MR imaging of gliomas: Initial experience and comparison with gadolinium enhancement.
8/2013	Nuclear Overhauser enhancement (NOE) imaging in the human brain at 7T.
7/2012	Assessment of MRI parameters as imaging biomarkers for radiation necrosis in the rat brain.
10/2011	Defining an Acidosis-Based Ischemic Penumbra from pH-Weighted MRI.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Peter C M van Zijl Research Topics

Disease

27	Neoplasms (Cancer) 06/2022 - 09/2006
12	Brain Neoplasms (Brain Tumor) 01/2022 - 12/2003
11	Glioma (Gliomas) 01/2019 - 07/2008
5	Alzheimer Disease (Alzheimer's Disease) 01/2021 - 03/2017
4	Neurodegenerative Diseases (Neurodegenerative Disease) 11/2021 - 06/2012
4	Huntington Disease (Huntington's Disease) 11/2021 - 11/2013
3	Cognitive Dysfunction 01/2021 - 06/2012
3	Disease Progression 01/2020 - 06/2012
3	Stroke (Strokes) 01/2017 - 08/2003
3	Necrosis 07/2012 - 06/2008
3	Gliosarcoma 01/2011 - 12/2003
2	Inflammation (Inflammations) 06/2022 - 01/2017
2	Sexually Transmitted Diseases (Sexually Transmitted Disease) 01/2021 - 04/2017
2	Ischemic Stroke 12/2020 - 07/2015
2	Amyloid Plaque 01/2020 - 01/2018
2	Adenocarcinoma 01/2019 - 03/2015
2	Glioblastoma (Glioblastoma Multiforme) 01/2019 - 06/2008
2	Acidosis 01/2017 - 10/2011
2	Nervous System Diseases (Neurological Disorders) 01/2015 - 05/2011
1	Dementia (Dementias) 01/2021
1	Demyelinating Diseases (Demyelinating Disease) 01/2021
1	Heart Diseases (Heart Disease) 11/2020
1	Glycogen Storage Disease (Glycogenosis) 11/2020
1	Multiple Sclerosis 01/2020
1	Pancreatic Neoplasms (Pancreatic Cancer) 01/2019
1	Prostatic Neoplasms (Prostate Cancer) 05/2018
1	Bacterial Infections (Bacterial Infection) 01/2018
1	Atrophy 01/2018
1	Cerebrovascular Disorders (Cerebrovascular Occlusion) 01/2018
1	Brain Abscess (Abscess, Brain) 01/2018
1	Pathologic Processes 03/2017
1	Reperfusion Injury 01/2017
1	Wounds and Injuries (Trauma) 01/2017
1	Hemorrhage 01/2017
1	Schizophrenia (Dementia Praecox) 04/2016
1	Restless Legs Syndrome (Restless Legs) 01/2016
1	Breast Neoplasms (Breast Cancer) 01/2016
1	Iron Deficiencies 01/2016
1	Brain Ischemia (Cerebral Ischemia) 07/2015
1	Cerebral Hemorrhage 07/2015
1	Ovarian Neoplasms (Ovarian Cancer) 03/2015

Drug/Important Bio-Agent (IBA)

22	Protons (Proton)IBA 01/2022 - 10/2002
20	AmidesIBA 01/2022 - 08/2003
16	Biomarkers (Surrogate Marker)IBA 06/2022 - 01/2011
16	APTIBA 01/2022 - 08/2003
11	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 12/2012
9	Contrast MediaIBA 01/2022 - 12/2012
8	Proteins (Proteins, Gene)FDA Link 11/2021 - 12/2003
6	IronIBA 01/2021 - 01/2016
5	GadoliniumIBA 01/2020 - 10/2008
4	Peptides (Polypeptides)IBA 01/2019 - 12/2003
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 10/2019 - 04/2014
3	Dextrans (Dextran)FDA Link 10/2019 - 01/2018
3	Liposomes (Liposome)IBA 01/2019 - 04/2014
3	Glutamic Acid (Glutamate)FDA Link 04/2016 - 06/2012
2	SugarsIBA 06/2022 - 12/2012
2	CreatineIBA 01/2021 - 01/2016
2	SolutionsIBA 01/2021 - 05/2018
2	Adenine FDA LinkGeneric 01/2019 - 11/2013
2	GuanineIBA 01/2019 - 11/2013
2	CytosineIBA 01/2019 - 11/2013
2	Indicators and Reagents (Reagents)IBA 01/2018 - 01/2016
2	Pharmaceutical PreparationsIBA 02/2016 - 01/2016
2	ferric oxide (iron oxide)IBA 07/2008 - 05/2008
1	Dichlorodiphenyl Dichloroethylene (DDE)IBA 01/2022
1	Amyloid (Amyloid Fibrils)IBA 01/2021
1	AminesIBA 12/2020
1	GlycogenIBA 11/2020
1	Apolipoprotein E4IBA 01/2020
1	Oxygen (Dioxygen)IBA 01/2020
1	Myelin ProteinsIBA 01/2020
1	ApolipoproteinsIBA 01/2020
1	IodineIBA 09/2019
1	Fibronectins (Fibronectin)IBA 01/2019
1	3-O-Methylglucose (3 O Methylglucose)IBA 01/2019
1	Sirolimus (Rapamycin)FDA Link 01/2019
1	TOR Serine-Threonine KinasesIBA 01/2019
1	Salicylic Acid (2 Hydroxybenzoic Acid)FDA LinkGeneric 05/2018
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2018
1	Ampicillin (Omnipen)FDA LinkGeneric 01/2018
1	Biological ProductsIBA 04/2017
1	Amyloid beta-PeptidesIBA 03/2017
1	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 01/2017
1	Cyclosporine (Ciclosporin)FDA LinkGeneric 01/2017
1	Messenger RNA (mRNA)IBA 01/2017
1	Glutamine (L-Glutamine)FDA Link 04/2016
1	Gemcitabine FDA Link 02/2016
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2016
1	Phosphocreatine (Neoton)IBA 01/2016
1	Inositol (Myoinositol)IBA 01/2016
1	Collagenases (Collagenase)FDA Link 07/2015
1	Nylons (Nylon)IBA 07/2015

Therapy/Procedure

4	Therapeutics 10/2019 - 01/2011
3	Precision Medicine 10/2019 - 02/2016
2	Aftercare (After-Treatment) 01/2019 - 12/2013
2	Drug Therapy (Chemotherapy) 01/2016 - 04/2014
1	Intravenous Injections 01/2019
1	Intraperitoneal Injections 01/2018
1	Neurosurgical Procedures 01/2017
1	Sutures (Suture) 07/2015